Ahmed Swidan, Gihan Hamdy Elsisi, Mohamed M. Ibrahim, Mohammad Aljazzar & Hossameldin Tawfik Sallam (2023) Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait, Journal of Medical Economics, 26:1, 271-282, DOI: 10.1080/13696998.2023.2174749 Elsisi GH, Afify A, Abgad A, Zakaria I, Nasif N, Ibrahim HN, Raafat N, Carapinha JL.(2022) A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt. Cost Eff Resour Alloc. 2022 Jan 15;20(1):1. doi: 10.1186/s12962-021-00335-y. PMID: 35033094; PMCID: PMC8760653. Abdelhamid M, Elsisi GH, Seyam A, Shafie A, Kirollos M, Emad S, Mansy S, Sobhy...
Publications
Published Posters
Elkony M, Elsisi G. Cost Minimization Analysis of Secukinumab versus Infliximab in Egyptian Patients with Ankylosing Spondylitis from Health Care Provider Perspective. Poster presentation PMS59 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain. Assal R, Elsisi G. Cost Effectiveness Analysis of Pegylated Liposomal and Nonliposomal Doxorubicin Formulations for the First Line Treatment of Metastatic Breast Cancer from Patient Perspective in Egypt. Poster presentation PCN160 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain. Elsisi G, Emad S, Hamed A. Are There Enough Regulations to Combat the Poor Quality Povidone-Iodine in Egypt. Poster presentation PHP341 at ISPOR 21th Annual European Congress, November 2018; Barcelona, Spain....